Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Definitive Healthcare (DH) EBITDA (2020 - 2025)

Definitive Healthcare's EBITDA history spans 6 years, with the latest figure at -$26.6 million for Q4 2025.

  • For Q4 2025, EBITDA rose 73.26% year-over-year to -$26.6 million; the TTM value through Dec 2025 reached -$224.3 million, up 68.45%, while the annual FY2025 figure was -$224.3 million, 68.45% up from the prior year.
  • EBITDA reached -$26.6 million in Q4 2025 per DH's latest filing, down from -$8.7 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of -$2.6 million in Q1 2021 to a low of -$369.6 million in Q2 2024.
  • Average EBITDA over 5 years is -$66.8 million, with a median of -$12.0 million recorded in 2022.
  • Peak YoY movement for EBITDA: crashed 2962.22% in 2024, then skyrocketed 98.87% in 2025.
  • A 5-year view of EBITDA shows it stood at -$13.1 million in 2021, then grew by 19.55% to -$10.5 million in 2022, then increased by 4.34% to -$10.1 million in 2023, then plummeted by 887.73% to -$99.6 million in 2024, then surged by 73.26% to -$26.6 million in 2025.
  • Per Business Quant, the three most recent readings for DH's EBITDA are -$26.6 million (Q4 2025), -$8.7 million (Q3 2025), and -$4.2 million (Q2 2025).